LiveWell
← Back to Protocol Library
Supplements
intermediate
Strong Evidence

Berberine for Metabolic Health

Berberine (500mg 2-3x/day with meals) activates AMPK and reduces blood glucose comparably to metformin. Strong evidence for improving fasting glucose, HbA1c, and lipids.

Time
2 min/day
Cost
$20-50
Equipment
None required
Min. Trial
8-12 weeks

Dosage & Timing

Duration
2 min
Frequency
2-3x daily with meals
Best Time
morning

Evidence Strength

4/5 — Strong

Strong evidence. Multiple RCTs and meta-analyses show significant reductions in fasting glucose (avg -15 mg/dL), HbA1c (-0.7%), triglycerides, and LDL. Yin et al. (2008) meta-analysis and Dong et al. (2012) meta-analysis are key references.

Overview

Take 500mg berberine 2-3 times daily with meals. Berberine activates AMPK (the same pathway as metformin) and has been shown to reduce fasting blood glucose, HbA1c, and LDL cholesterol. Multiple meta-analyses demonstrate glucose-lowering effects comparable to metformin in type 2 diabetes.

How To Do It

1

Start low

Begin with 500mg once daily with your largest meal. GI side effects (cramping, diarrhea) are common initially.

2

Increase gradually

After 1-2 weeks, increase to 500mg twice daily. Target dose: 500mg 2-3x/day with meals.

3

Take with food

Always take with meals to improve absorption and reduce GI side effects.

4

Monitor blood markers

Check fasting glucose and HbA1c at baseline and after 8-12 weeks. Also monitor lipid panel.

The Evidence

Each claim is linked to its source study. Confidence reflects the study design — systematic reviews and RCTs rank highest.

Berberine improved glycemic and lipid markers in adults with type 2 diabetes.

Primary Literature

Clinical Trial:Treatment of type 2 diabetes and dyslipidemia with berberine (https://pubmed.ncbi.nlm.nih.gov/18397984/)

Who Popularized This

Rhonda Patrick
Peter Attia

Interactions & Warnings

Contraindications

  • Pregnancy and breastfeeding
  • Severe liver or kidney disease
  • Children

Interactions

  • May potentiate diabetes medications (risk of hypoglycemia)
  • Inhibits CYP3A4/CYP2D6 — check drug interactions
  • Do not combine with metformin without medical supervision

Measurable Outcomes

Reduced fasting blood glucose
Lower HbA1c
Improved lipid panel (LDL, triglycerides)
Reduced waist circumference
Browse More Protocols

Related Protocols